A Pilot Study of Probiotic Saccharomyces Boulardii Use in Chronic Heart Failure Patients. Estudo PROICA
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the feasibility, safety and effects in inflammatory
response of the therapy with a probiotic agent, the yeast Saccharomyces boulardii (SB), in
chronic heart failure patients.